LeeS Posted July 13, 2012 Posted July 13, 2012 Love Professor Nutt's job title mate. Perhaps I can aspire to be a neuropsychopharmacologicalchronobiologist? See you in the Queens Larder before the games kick-off? -Lee Quote
Bejeeber Posted July 14, 2012 Posted July 14, 2012 Love Professor Nutt's job title Whoever titled Nutt's job must be a real .....nut job. Ahem. Sorry about that one. [smiley=tongue.gif] Quote
shocked Posted August 1, 2012 Author Posted August 1, 2012 Dr Robin Carhart Harris Interview shocked Quote
shocked Posted August 1, 2012 Author Posted August 1, 2012 Dr. Robin Carhart-Harris - Psilocybin and the Psychedelic State Dr. Robin Carhart-Harris, of the Neuropsychopharmacology Unit, Imperial College London, discusses research on Psilocybin and how psychedelics could be used in therapy to help with depression, addiction, and other problems of rigid thought patterns. Interview shot as part of forthcoming 3D Consciousness documentary. Filmmaker: Matt Faw shocked Quote
shocked Posted August 1, 2012 Author Posted August 1, 2012 Research into the effects of MDMA on the resting brain to be shown on Channel 4 Imperial research on MDMA, the pure form of Class A drug ecstasy will be shown on two new science programmes this autumn. http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/newssummary/news_23-7-2012-15-42-26 Keith Allen defends "radical" drugs documentary http://m.bbc.co.uk/news/entertainment-arts-18855311 Lily Allen's father to take ecstasy on TV: Backlash over Channel 4's drugs stunt http://www.dailymail.co.uk/news/article-2174104/Lily-Allens-father-Keith-ecstasy-TV-Backlash-Channel-4s-drugs-stunt.html shocked Quote
shocked Posted September 7, 2012 Author Posted September 7, 2012 Could Mind-Expanding Drugs Lead to Medical Breakthroughs? A Q&A with David Nutt and Robin Carhart-Harris http://www.dana.org/news/features/detail.aspx?id=39552 The DANA Foundation shocked Quote
shocked Posted September 25, 2012 Author Posted September 25, 2012 Can LSD cure depression? Controversial research suggests that LSD and other psychedelic drugs could have vital medical uses. http://www.telegraph.co.uk/science/9565026/Can-LSD-cure-depression.html Earlier studies have made surprising discoveries about what psilocybin, a class-A drug in Britain, was doing in the brain. These in turn could lead to new treatments for depression and agonising cluster headaches. says Carhart-Harris shocked Quote
shocked Posted March 27, 2013 Author Posted March 27, 2013 In the near future Cahart-Harris will be carrying out two new exciting experimental studies. One is with psilocybin, the psychoactive ingredient in magic mushrooms; the second is on LSD http://thebackbencher.co.uk/is-psychedelic-therapy-the-future/ shocked Quote
shocked Posted March 29, 2013 Author Posted March 29, 2013 Drop in Lecture http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/eventssummary/event_27-3-2013-14-46-32 shocked Quote
shocked Posted April 8, 2013 Author Posted April 8, 2013 BNA Festival of Neuroscience press release – http://www.bna2013.com/TFI/media/uploaded/EVTFI/event_556/2.%20Nutt_magic%20mushrooms.pdf a selection from the media - http://news.sky.com/story/1074892/magic-mushroom-depression-trials-stalled http://www.dailymail.co.uk/health/article-2305108/Sacked-drugs-tsar-handed-1-2m-magic-mushrooms-cure-depression-trial-backed-aristocrat-dubbed-Lady-Mindbender.html http://www.youtube.com/watch?v=4lTUZxqAYS0 shocked Quote
shocked Posted April 15, 2013 Author Posted April 15, 2013 The Beckley Foundation/Imperial College Psychopharmacalogical Research Programme http://www.beckleyfoundation.org/wp-content/uploads/2013/04/Beckley-Imperial-psychopharmacological-flyer-130402.pdf Exciting new breakthroughs in the world of psychedelic research – a pioneering collaboration between Amanda Feilding, Director of the Beckley Foundation, David Nutt, Professor of Neuropsychopharmacology at Imperial College, London and Dr Robin Carhart-Harris, a Beckley Fellow at Imperial College The Beckley-Imperial Programme works at the frontiers of research into psychoactive substances, their effects on the brain and consciousness, and their potential therapeutic benefits. Our recent series of studies into psilocybin began in 2009 and used the latest brain-imaging technology (fMRI and MEG) to investigate changes in blood supply to the brain, correlated with changes in brain activity and subjective experience, when volunteers received an intravenous dose of the drug. … The findings raise exciting possibilities for the therapeutic use of psilocybin. One of the ‘hub’ regions, the medial prefrontal cortex, is known to be chronically over-active in depression. This same region has its activity throttled by psilocybin because its blood supply is reduced. Another region (the hypothalamus), which is over-active in the agonising condition of cluster headaches, also has its activity reduced by psilocybin through decreased blood supply. Thus our research has already thrown light on potentially valuable new avenues of treatment for both these debilitating conditions. … These insights have generated a major Medical Research Council (MRC) grant for a study into the use of psilocybin in the treatment of depression, which has recently received ethical approval. This is the first time a government body has funded psyche-delic research. … The recent findings in the Beckley/Imperial Programme demonstrate why it is essential to expand research into the therapeutic potential of currently illegal psychotropic drugs. The taboo on these substances, which comes from their illicit status, has severely impeded both scientific research into how these ancient medicinal and spiritually awakening compounds work, and clinical use of these substances for the treatment of some of modern man's many ills. We ask all interested parties to help us develop and expand our programme of work. The time for this vital research has finally come… shocked Quote
CHfather Posted April 15, 2013 Posted April 15, 2013 As so many times before, thank you, shocked. This is really interesting, and hopeful, information. Quote
shocked Posted May 17, 2013 Author Posted May 17, 2013 Still Fighting Professor David Nutt Interview http://www.vice.com/en_uk/read/david-nutt-magic-mushrooms-interview Are there any other studies in the UK or Europe that are currently encountering roadblocks due to the difficulty of acquiring the product for clinical trials? Absolutely… There are non-hallucinogenic derivatives of LSD, like 2-Bromo-LSD, that may cure cluster headaches – a terrible, terrible illness. We believe that it's outside the act. It’s not psychedelic, so why would it be controlled? But the Home Office takes the view that, because it’s got LSD in its name, they’ve got to control it. That must be frustrating for you? It's more frustrating for the people who are suffering. I got an email last week from a guy in Texas saying, “I suffered so much from cluster headaches that my son offered to kill me.” He said, “I now live in Mexico because in Mexico they allow you to use mushrooms for health reasons.” He was empowered to do that, but most people aren't. And I just hate to see suffering based on these lies about the drugs being too harmful to use. shocked Quote
shocked Posted May 24, 2013 Author Posted May 24, 2013 Drop in Lecture video How do psychedelic drugs work on the brain? Dr Robin Carhart-Harris tackles the difficult question of how certain drugs produce hallucinogenic qualities in our brains. http://wwwf.imperial.ac.uk/imedia/content/view/3704/how-do-psychedelic-drugs-work-on-the-brain shocked Quote
shocked Posted June 15, 2013 Author Posted June 15, 2013 Professor David Nutt - Drug Science | London Real . Mentions busting briefly, explaining “defence of necessity” at 42 minutes. Psilocybin research at 48:00 – 56:40 minutes. shocked Quote
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.